Artículos por temáticas

Barthel Index and modified Rankin Scale: Psychometric properties during medication phases in idiopathic Parkinson disease.

Taghizadeh G, Martinez-Martin P, Meimandi M, Habibi SAH, Jamali S, Dehmiyani A, Rostami S, Mahmuodi A, Mehdizadeh M, Fereshtehnejad SM.

Ann Phys Rehabil Med. 2019 Dec 6. pii: S1877-0657(19)30185-X. doi: 10.1016/j.rehab.2019.08.006. [Epub ahead of print]

Psychiatric Patients on Neuroleptics: Evaluation of Parkinsonism and Quantified Assessment of Gait

Yahalom H, Israeli-Korn S, Linder M, Yekutieli Z, Karlinsky KT, Rubel Y, Livneh V, Fay-Karmon T, Hassin-Baer S, Yahalom G.

Clin Neuropharmacol. 2020 Jan/Feb;43(1):1-6. doi: 10.1097/WNF.0000000000000371.

Ten Years of the International Parkinson Disease Genomics Consortium: Progress and Next Steps

International Parkinson Disease Genomics Consortium (IPDGC).

J Parkinsons Dis. 2020;10(1):19-30. doi: 10.3233/JPD-191854.

Repeated Intravenous Amantadine Infusions in Advanced Parkinsonism: Experience of a Large Movement Disorder Center.

Kestenbaum M, Abu Snineh M, Nussbaum T, Gadoth A, Rosenberg A, Hindi A, Zitser J, Thaler A, Giladi N, Gurevich T.

Isr Med Assoc J. 2019 Dec;12(21):812-816.

G2019S-LRRK2 mutation enhances MPTP-linked Parkinsonism in mice

Arbez N, He X, Huang Y, Ren M, Liang Y, Nucifora FC, Wang X, Pei Z, Tessarolo L, Smith WW, Ross CA.

Hum Mol Genet. 2020 Mar 13;29(4):580-590. doi: 10.1093/hmg/ddz271.

Protective Effect of (-)Epigallocatechin-3-gallate on Rotenone-Induced Parkinsonism-like Symptoms in Rats

Tseng HC, Wang MH, Chang KC, Soung HS, Fang CH, Lin YW, Li KY, Yang CC, Tsai CC.

Neurotox Res. 2020 Mar;37(3):669-682. doi: 10.1007/s12640-019-00143-6. Epub 2019 Dec 6.

Visual Hallucinations and Impaired Conscious Visual Perception in Parkinson Disease

Kurita A, Koshikawa H, Akiba T, Seki K, Ishikawa H, Suzuki M.

J Geriatr Psychiatry Neurol. 2020 Nov;33(6):377-385. doi: 10.1177/0891988719892318. Epub 2019 Dec 6.

Suicidal risk and demoralization in Parkinson disease

Elfil M, Ahmed N, Alapati A, Bahekar R, Kandil M, Kim C, Schaefer S, Tinaz S, Patel AS, de Figueiredo JM, Louis ED, Koo BB.

J Neurol. 2020 Apr;267(4):966-974. doi: 10.1007/s00415-019-09632-2. Epub 2019 Dec 4.

Emotion Recognition in Patients With Parkinson Disease.

Chen HB, Wu DD, He J, Li SH, Su W.

Cogn Behav Neurol. 2019 Dec;32(4):247-255. doi: 10.1097/WNN.0000000000000209.

Modulation of key enzymes linked to Parkinsonism and neurologic disorders by Antiaris africana in rotenone-toxified rats.

Ilesanmi OB, Akinmoladun AC, Josiah SS, Olaleye MT, Akindahunsi AA.

J Basic Clin Physiol Pharmacol. 2019 Dec 4. pii: /j/jbcpp.ahead-of-print/jbcpp-2019-0014/jbcpp-2019-0014.xml. doi: 10.1515/jbcpp-2019-0014. [Epub ahead of print]

Clinical and neuroimaging phenotypes of genetic parkinsonism from infancy to adolescence

Morales-Briceño H, Mohammad SS, Post B, Fois AF, Dale RC, Tchan M, Fung VSC.

Brain. 2020 Mar 1;143(3):751-770. doi: 10.1093/brain/awz345.

Frequency and Dynamics of Non-motor Symptoms Presentation in Hispanic Patients With Parkinson Disease.

Sánchez-Martínez CM, Choreño-Parra JA, Placencia-Álvarez N, Nuñez-Orozco L, Guadarrama-Ortiz P.

Front Neurol. 2019 Nov 14;10:1197. doi: 10.3389/fneur.2019.01197. eCollection 2019.

Dietary Supplement Use is High among Individuals with Parkinson Disease.

Ferguson CC, Knol LL, Halli-Tierney A, Ellis AC.

South Med J. 2019 Dec;112(12):621-625. doi: 10.14423/SMJ.0000000000001041.

The risk of hip and non-vertebral fractures in patients with Parkinson's disease and parkinsonism: A systematic review and meta-analysis

Schini M, Vilaca T, Poku E, Harnan S, Sutton A, Allen IE, Cummings SR, Eastell R.

Bone. 2020 Mar;132:115173. doi: 10.1016/j.bone.2019.115173. Epub 2019 Nov 29.

Clinical evaluation of sibling pairs with gaucher disease discordant for parkinsonism

Lopez G, Steward A, Ryan E, Groden C, Wiggs E, Segalà L, Monestime GM, Tayebi N, Sidransky E.

Mov Disord. 2020 Feb;35(2):359-365. doi: 10.1002/mds.27916. Epub 2019 Nov 30.